nodes	percent_of_prediction	percent_of_DWPC	metapath
Avanafil—CYP3A4—Temozolomide—melanoma	0.271	0.576	CbGbCtD
Avanafil—PDE5A—clitoris—melanoma	0.189	0.728	CbGeAlD
Avanafil—CYP3A4—Vemurafenib—melanoma	0.148	0.316	CbGbCtD
Avanafil—CYP3A4—Docetaxel—melanoma	0.0509	0.108	CbGbCtD
Avanafil—PDE5A—endothelium—melanoma	0.0209	0.0806	CbGeAlD
Avanafil—PDE5A—blood vessel—melanoma	0.0193	0.0744	CbGeAlD
Avanafil—PDE5A—eye—melanoma	0.0103	0.0396	CbGeAlD
Avanafil—PDE5A—retina—melanoma	0.0102	0.0392	CbGeAlD
Avanafil—Angina unstable—Docetaxel—melanoma	0.00723	0.0267	CcSEcCtD
Avanafil—PDE5A—head—melanoma	0.00582	0.0225	CbGeAlD
Avanafil—Musculoskeletal pain—Vemurafenib—melanoma	0.00544	0.0201	CcSEcCtD
Avanafil—Deep vein thrombosis—Temozolomide—melanoma	0.00451	0.0167	CcSEcCtD
Avanafil—PDE5A—lymph node—melanoma	0.00408	0.0157	CbGeAlD
Avanafil—Pain in extremity—Vemurafenib—melanoma	0.0039	0.0144	CcSEcCtD
Avanafil—Wheezing—Bleomycin—melanoma	0.00316	0.0117	CcSEcCtD
Avanafil—Infestation NOS—Vemurafenib—melanoma	0.00301	0.0111	CcSEcCtD
Avanafil—Infestation—Vemurafenib—melanoma	0.00301	0.0111	CcSEcCtD
Avanafil—Deep vein thrombosis—Docetaxel—melanoma	0.003	0.0111	CcSEcCtD
Avanafil—Hepatic enzyme increased—Temozolomide—melanoma	0.0029	0.0107	CcSEcCtD
Avanafil—Musculoskeletal pain—Temozolomide—melanoma	0.00278	0.0103	CcSEcCtD
Avanafil—Influenza like illness—Temozolomide—melanoma	0.00267	0.00986	CcSEcCtD
Avanafil—Oedema peripheral—Vemurafenib—melanoma	0.00266	0.00983	CcSEcCtD
Avanafil—Connective tissue disorder—Vemurafenib—melanoma	0.00265	0.0098	CcSEcCtD
Avanafil—Eye disorder—Vemurafenib—melanoma	0.00252	0.00932	CcSEcCtD
Avanafil—Cardiac disorder—Vemurafenib—melanoma	0.0025	0.00926	CcSEcCtD
Avanafil—Angiopathy—Vemurafenib—melanoma	0.00245	0.00905	CcSEcCtD
Avanafil—Mediastinal disorder—Vemurafenib—melanoma	0.00243	0.00899	CcSEcCtD
Avanafil—Diabetes mellitus—Carmustine—melanoma	0.00237	0.00877	CcSEcCtD
Avanafil—Malnutrition—Vemurafenib—melanoma	0.00235	0.00868	CcSEcCtD
Avanafil—Back pain—Vemurafenib—melanoma	0.00227	0.0084	CcSEcCtD
Avanafil—Rhinorrhoea—Docetaxel—melanoma	0.00225	0.00833	CcSEcCtD
Avanafil—Nasal congestion—Temozolomide—melanoma	0.00219	0.00809	CcSEcCtD
Avanafil—Hot flush—Temozolomide—melanoma	0.00213	0.00788	CcSEcCtD
Avanafil—Menopausal symptoms—Temozolomide—melanoma	0.00211	0.00781	CcSEcCtD
Avanafil—Cough—Vemurafenib—melanoma	0.00205	0.00758	CcSEcCtD
Avanafil—Oropharyngeal pain—Docetaxel—melanoma	0.00201	0.00742	CcSEcCtD
Avanafil—Myalgia—Vemurafenib—melanoma	0.002	0.00739	CcSEcCtD
Avanafil—Arthralgia—Vemurafenib—melanoma	0.002	0.00739	CcSEcCtD
Avanafil—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.00199	0.00734	CcSEcCtD
Avanafil—Blood bilirubin increased—Docetaxel—melanoma	0.00193	0.00714	CcSEcCtD
Avanafil—Infection—Vemurafenib—melanoma	0.0019	0.00704	CcSEcCtD
Avanafil—Nervous system disorder—Vemurafenib—melanoma	0.00188	0.00695	CcSEcCtD
Avanafil—Skin disorder—Vemurafenib—melanoma	0.00186	0.00688	CcSEcCtD
Avanafil—Blood pressure increased—Docetaxel—melanoma	0.00183	0.00675	CcSEcCtD
Avanafil—Breast disorder—Temozolomide—melanoma	0.0018	0.00666	CcSEcCtD
Avanafil—Hypotension—Vemurafenib—melanoma	0.00179	0.00662	CcSEcCtD
Avanafil—Influenza like illness—Docetaxel—melanoma	0.00177	0.00656	CcSEcCtD
Avanafil—Alanine aminotransferase increased—Temozolomide—melanoma	0.00176	0.0065	CcSEcCtD
Avanafil—Musculoskeletal discomfort—Vemurafenib—melanoma	0.00175	0.00646	CcSEcCtD
Avanafil—Haematuria—Bleomycin—melanoma	0.00174	0.00642	CcSEcCtD
Avanafil—Bronchitis—Temozolomide—melanoma	0.00166	0.00613	CcSEcCtD
Avanafil—Gastrointestinal disorder—Vemurafenib—melanoma	0.00165	0.00612	CcSEcCtD
Avanafil—Fatigue—Vemurafenib—melanoma	0.00165	0.00611	CcSEcCtD
Avanafil—Constipation—Vemurafenib—melanoma	0.00164	0.00606	CcSEcCtD
Avanafil—Upper respiratory tract infection—Temozolomide—melanoma	0.0016	0.00592	CcSEcCtD
Avanafil—Pollakiuria—Temozolomide—melanoma	0.00159	0.00588	CcSEcCtD
Avanafil—Weight increased—Temozolomide—melanoma	0.00157	0.0058	CcSEcCtD
Avanafil—Urinary tract infection—Carmustine—melanoma	0.00154	0.00571	CcSEcCtD
Avanafil—Infestation NOS—Temozolomide—melanoma	0.00154	0.00568	CcSEcCtD
Avanafil—Infestation—Temozolomide—melanoma	0.00154	0.00568	CcSEcCtD
Avanafil—Flushing—Bleomycin—melanoma	0.00152	0.00561	CcSEcCtD
Avanafil—Body temperature increased—Vemurafenib—melanoma	0.00152	0.0056	CcSEcCtD
Avanafil—Urinary tract infection—Temozolomide—melanoma	0.00149	0.00552	CcSEcCtD
Avanafil—Sinusitis—Temozolomide—melanoma	0.00144	0.00533	CcSEcCtD
Avanafil—Hot flush—Docetaxel—melanoma	0.00142	0.00524	CcSEcCtD
Avanafil—Flushing—Dactinomycin—melanoma	0.00141	0.00523	CcSEcCtD
Avanafil—Oedema peripheral—Carmustine—melanoma	0.00141	0.0052	CcSEcCtD
Avanafil—Menopausal symptoms—Docetaxel—melanoma	0.0014	0.00519	CcSEcCtD
Avanafil—Connective tissue disorder—Carmustine—melanoma	0.0014	0.00518	CcSEcCtD
Avanafil—Asthenia—Vemurafenib—melanoma	0.00138	0.00508	CcSEcCtD
Avanafil—Urinary tract disorder—Temozolomide—melanoma	0.00136	0.00503	CcSEcCtD
Avanafil—Oedema peripheral—Temozolomide—melanoma	0.00136	0.00502	CcSEcCtD
Avanafil—Pruritus—Vemurafenib—melanoma	0.00136	0.00501	CcSEcCtD
Avanafil—Connective tissue disorder—Temozolomide—melanoma	0.00135	0.00501	CcSEcCtD
Avanafil—Urethral disorder—Temozolomide—melanoma	0.00135	0.005	CcSEcCtD
Avanafil—Eye disorder—Carmustine—melanoma	0.00133	0.00493	CcSEcCtD
Avanafil—Pain in extremity—Docetaxel—melanoma	0.00133	0.0049	CcSEcCtD
Avanafil—Flushing—Carmustine—melanoma	0.00132	0.0049	CcSEcCtD
Avanafil—Diarrhoea—Vemurafenib—melanoma	0.00131	0.00485	CcSEcCtD
Avanafil—Eye disorder—Temozolomide—melanoma	0.00129	0.00476	CcSEcCtD
Avanafil—Cardiac disorder—Temozolomide—melanoma	0.00128	0.00473	CcSEcCtD
Avanafil—Flushing—Temozolomide—melanoma	0.00128	0.00473	CcSEcCtD
Avanafil—Dizziness—Vemurafenib—melanoma	0.00127	0.00469	CcSEcCtD
Avanafil—Angiopathy—Temozolomide—melanoma	0.00125	0.00463	CcSEcCtD
Avanafil—Mental disorder—Carmustine—melanoma	0.00125	0.00462	CcSEcCtD
Avanafil—Immune system disorder—Temozolomide—melanoma	0.00125	0.0046	CcSEcCtD
Avanafil—Mediastinal disorder—Temozolomide—melanoma	0.00124	0.00459	CcSEcCtD
Avanafil—Malnutrition—Carmustine—melanoma	0.00124	0.00459	CcSEcCtD
Avanafil—Cough—Bleomycin—melanoma	0.00124	0.00459	CcSEcCtD
Avanafil—Vomiting—Vemurafenib—melanoma	0.00122	0.00451	CcSEcCtD
Avanafil—Myalgia—Bleomycin—melanoma	0.00121	0.00448	CcSEcCtD
Avanafil—Chest pain—Bleomycin—melanoma	0.00121	0.00448	CcSEcCtD
Avanafil—Rash—Vemurafenib—melanoma	0.00121	0.00447	CcSEcCtD
Avanafil—Mental disorder—Temozolomide—melanoma	0.00121	0.00447	CcSEcCtD
Avanafil—Dermatitis—Vemurafenib—melanoma	0.00121	0.00446	CcSEcCtD
Avanafil—Back pain—Carmustine—melanoma	0.0012	0.00444	CcSEcCtD
Avanafil—Headache—Vemurafenib—melanoma	0.0012	0.00444	CcSEcCtD
Avanafil—Malnutrition—Temozolomide—melanoma	0.0012	0.00444	CcSEcCtD
Avanafil—Breast disorder—Docetaxel—melanoma	0.0012	0.00443	CcSEcCtD
Avanafil—Nasopharyngitis—Docetaxel—melanoma	0.00119	0.00438	CcSEcCtD
Avanafil—Vision blurred—Carmustine—melanoma	0.00117	0.00433	CcSEcCtD
Avanafil—Alanine aminotransferase increased—Docetaxel—melanoma	0.00117	0.00432	CcSEcCtD
Avanafil—Back pain—Temozolomide—melanoma	0.00116	0.00429	CcSEcCtD
Avanafil—Infection—Bleomycin—melanoma	0.00115	0.00427	CcSEcCtD
Avanafil—Agitation—Carmustine—melanoma	0.00114	0.00422	CcSEcCtD
Avanafil—Nausea—Vemurafenib—melanoma	0.00114	0.00421	CcSEcCtD
Avanafil—Vision blurred—Temozolomide—melanoma	0.00113	0.00418	CcSEcCtD
Avanafil—Myalgia—Dactinomycin—melanoma	0.00113	0.00418	CcSEcCtD
Avanafil—Angina pectoris—Docetaxel—melanoma	0.00112	0.00413	CcSEcCtD
Avanafil—Agitation—Temozolomide—melanoma	0.0011	0.00408	CcSEcCtD
Avanafil—Hypotension—Bleomycin—melanoma	0.00109	0.00401	CcSEcCtD
Avanafil—Vertigo—Temozolomide—melanoma	0.00108	0.00399	CcSEcCtD
Avanafil—Infection—Dactinomycin—melanoma	0.00108	0.00398	CcSEcCtD
Avanafil—Hypertension—Carmustine—melanoma	0.00107	0.00396	CcSEcCtD
Avanafil—Palpitations—Temozolomide—melanoma	0.00106	0.00392	CcSEcCtD
Avanafil—Musculoskeletal discomfort—Bleomycin—melanoma	0.00106	0.00391	CcSEcCtD
Avanafil—Myalgia—Carmustine—melanoma	0.00106	0.00391	CcSEcCtD
Avanafil—Chest pain—Carmustine—melanoma	0.00106	0.00391	CcSEcCtD
Avanafil—Cough—Temozolomide—melanoma	0.00105	0.00387	CcSEcCtD
Avanafil—Weight increased—Docetaxel—melanoma	0.00104	0.00385	CcSEcCtD
Avanafil—Hypertension—Temozolomide—melanoma	0.00104	0.00383	CcSEcCtD
Avanafil—Arthralgia—Temozolomide—melanoma	0.00102	0.00378	CcSEcCtD
Avanafil—Myalgia—Temozolomide—melanoma	0.00102	0.00378	CcSEcCtD
Avanafil—Infestation NOS—Docetaxel—melanoma	0.00102	0.00378	CcSEcCtD
Avanafil—Infestation—Docetaxel—melanoma	0.00102	0.00378	CcSEcCtD
Avanafil—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.00101	0.00375	CcSEcCtD
Avanafil—Infection—Carmustine—melanoma	0.00101	0.00372	CcSEcCtD
Avanafil—Dry mouth—Temozolomide—melanoma	0.000999	0.00369	CcSEcCtD
Avanafil—Tachycardia—Carmustine—melanoma	0.000989	0.00366	CcSEcCtD
Avanafil—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000987	0.00365	CcSEcCtD
Avanafil—Infection—Temozolomide—melanoma	0.000973	0.0036	CcSEcCtD
Avanafil—Epistaxis—Docetaxel—melanoma	0.000963	0.00356	CcSEcCtD
Avanafil—Nervous system disorder—Temozolomide—melanoma	0.000961	0.00355	CcSEcCtD
Avanafil—Skin disorder—Temozolomide—melanoma	0.000951	0.00352	CcSEcCtD
Avanafil—Hypotension—Carmustine—melanoma	0.000947	0.0035	CcSEcCtD
Avanafil—Fatigue—Dactinomycin—melanoma	0.000934	0.00345	CcSEcCtD
Avanafil—Musculoskeletal discomfort—Carmustine—melanoma	0.000923	0.00341	CcSEcCtD
Avanafil—Body temperature increased—Bleomycin—melanoma	0.000918	0.00339	CcSEcCtD
Avanafil—Insomnia—Carmustine—melanoma	0.000917	0.00339	CcSEcCtD
Avanafil—Urinary tract disorder—Docetaxel—melanoma	0.000905	0.00335	CcSEcCtD
Avanafil—Oedema peripheral—Docetaxel—melanoma	0.000903	0.00334	CcSEcCtD
Avanafil—Somnolence—Carmustine—melanoma	0.000901	0.00333	CcSEcCtD
Avanafil—Connective tissue disorder—Docetaxel—melanoma	0.000901	0.00333	CcSEcCtD
Avanafil—Urethral disorder—Docetaxel—melanoma	0.000899	0.00332	CcSEcCtD
Avanafil—Musculoskeletal discomfort—Temozolomide—melanoma	0.000892	0.0033	CcSEcCtD
Avanafil—Insomnia—Temozolomide—melanoma	0.000886	0.00328	CcSEcCtD
Avanafil—Gastrointestinal disorder—Carmustine—melanoma	0.000875	0.00324	CcSEcCtD
Avanafil—Somnolence—Temozolomide—melanoma	0.000871	0.00322	CcSEcCtD
Avanafil—Constipation—Carmustine—melanoma	0.000867	0.0032	CcSEcCtD
Avanafil—Dyspepsia—Temozolomide—melanoma	0.000862	0.00319	CcSEcCtD
Avanafil—Eye disorder—Docetaxel—melanoma	0.000857	0.00317	CcSEcCtD
Avanafil—Body temperature increased—Dactinomycin—melanoma	0.000856	0.00317	CcSEcCtD
Avanafil—Flushing—Docetaxel—melanoma	0.000851	0.00315	CcSEcCtD
Avanafil—Cardiac disorder—Docetaxel—melanoma	0.000851	0.00315	CcSEcCtD
Avanafil—Gastrointestinal disorder—Temozolomide—melanoma	0.000846	0.00313	CcSEcCtD
Avanafil—Fatigue—Temozolomide—melanoma	0.000844	0.00312	CcSEcCtD
Avanafil—Constipation—Temozolomide—melanoma	0.000838	0.0031	CcSEcCtD
Avanafil—Asthenia—Bleomycin—melanoma	0.000833	0.00308	CcSEcCtD
Avanafil—Angiopathy—Docetaxel—melanoma	0.000832	0.00308	CcSEcCtD
Avanafil—Immune system disorder—Docetaxel—melanoma	0.000828	0.00306	CcSEcCtD
Avanafil—Mediastinal disorder—Docetaxel—melanoma	0.000826	0.00306	CcSEcCtD
Avanafil—Pruritus—Bleomycin—melanoma	0.000822	0.00304	CcSEcCtD
Avanafil—Mental disorder—Docetaxel—melanoma	0.000803	0.00297	CcSEcCtD
Avanafil—Body temperature increased—Carmustine—melanoma	0.000801	0.00296	CcSEcCtD
Avanafil—Malnutrition—Docetaxel—melanoma	0.000798	0.00295	CcSEcCtD
Avanafil—Asthenia—Dactinomycin—melanoma	0.000777	0.00287	CcSEcCtD
Avanafil—Body temperature increased—Temozolomide—melanoma	0.000774	0.00286	CcSEcCtD
Avanafil—Back pain—Docetaxel—melanoma	0.000772	0.00285	CcSEcCtD
Avanafil—Muscle spasms—Docetaxel—melanoma	0.000767	0.00284	CcSEcCtD
Avanafil—Diarrhoea—Dactinomycin—melanoma	0.000741	0.00274	CcSEcCtD
Avanafil—Vomiting—Bleomycin—melanoma	0.000738	0.00273	CcSEcCtD
Avanafil—Rash—Bleomycin—melanoma	0.000732	0.00271	CcSEcCtD
Avanafil—Dermatitis—Bleomycin—melanoma	0.000731	0.0027	CcSEcCtD
Avanafil—Asthenia—Carmustine—melanoma	0.000727	0.00269	CcSEcCtD
Avanafil—Palpitations—Docetaxel—melanoma	0.000705	0.00261	CcSEcCtD
Avanafil—Asthenia—Temozolomide—melanoma	0.000703	0.0026	CcSEcCtD
Avanafil—Cough—Docetaxel—melanoma	0.000696	0.00258	CcSEcCtD
Avanafil—Diarrhoea—Carmustine—melanoma	0.000693	0.00256	CcSEcCtD
Avanafil—Pruritus—Temozolomide—melanoma	0.000693	0.00256	CcSEcCtD
Avanafil—Nausea—Bleomycin—melanoma	0.00069	0.00255	CcSEcCtD
Avanafil—Hypertension—Docetaxel—melanoma	0.000689	0.00255	CcSEcCtD
Avanafil—Vomiting—Dactinomycin—melanoma	0.000689	0.00255	CcSEcCtD
Avanafil—Rash—Dactinomycin—melanoma	0.000683	0.00252	CcSEcCtD
Avanafil—Chest pain—Docetaxel—melanoma	0.000679	0.00251	CcSEcCtD
Avanafil—Myalgia—Docetaxel—melanoma	0.000679	0.00251	CcSEcCtD
Avanafil—Arthralgia—Docetaxel—melanoma	0.000679	0.00251	CcSEcCtD
Avanafil—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000675	0.0025	CcSEcCtD
Avanafil—Dizziness—Carmustine—melanoma	0.00067	0.00248	CcSEcCtD
Avanafil—Diarrhoea—Temozolomide—melanoma	0.00067	0.00248	CcSEcCtD
Avanafil—Dry mouth—Docetaxel—melanoma	0.000665	0.00246	CcSEcCtD
Avanafil—Dizziness—Temozolomide—melanoma	0.000648	0.00239	CcSEcCtD
Avanafil—Infection—Docetaxel—melanoma	0.000647	0.00239	CcSEcCtD
Avanafil—Vomiting—Carmustine—melanoma	0.000644	0.00238	CcSEcCtD
Avanafil—Nausea—Dactinomycin—melanoma	0.000643	0.00238	CcSEcCtD
Avanafil—Rash—Carmustine—melanoma	0.000639	0.00236	CcSEcCtD
Avanafil—Nervous system disorder—Docetaxel—melanoma	0.000639	0.00236	CcSEcCtD
Avanafil—Dermatitis—Carmustine—melanoma	0.000638	0.00236	CcSEcCtD
Avanafil—Tachycardia—Docetaxel—melanoma	0.000636	0.00235	CcSEcCtD
Avanafil—Headache—Carmustine—melanoma	0.000635	0.00235	CcSEcCtD
Avanafil—Skin disorder—Docetaxel—melanoma	0.000633	0.00234	CcSEcCtD
Avanafil—Vomiting—Temozolomide—melanoma	0.000623	0.0023	CcSEcCtD
Avanafil—Rash—Temozolomide—melanoma	0.000618	0.00228	CcSEcCtD
Avanafil—Dermatitis—Temozolomide—melanoma	0.000617	0.00228	CcSEcCtD
Avanafil—Headache—Temozolomide—melanoma	0.000614	0.00227	CcSEcCtD
Avanafil—Hypotension—Docetaxel—melanoma	0.000609	0.00225	CcSEcCtD
Avanafil—Nausea—Carmustine—melanoma	0.000602	0.00223	CcSEcCtD
Avanafil—Musculoskeletal discomfort—Docetaxel—melanoma	0.000593	0.00219	CcSEcCtD
Avanafil—Insomnia—Docetaxel—melanoma	0.000589	0.00218	CcSEcCtD
Avanafil—Nausea—Temozolomide—melanoma	0.000582	0.00215	CcSEcCtD
Avanafil—Somnolence—Docetaxel—melanoma	0.000579	0.00214	CcSEcCtD
Avanafil—Dyspepsia—Docetaxel—melanoma	0.000573	0.00212	CcSEcCtD
Avanafil—Gastrointestinal disorder—Docetaxel—melanoma	0.000562	0.00208	CcSEcCtD
Avanafil—Fatigue—Docetaxel—melanoma	0.000562	0.00208	CcSEcCtD
Avanafil—Constipation—Docetaxel—melanoma	0.000557	0.00206	CcSEcCtD
Avanafil—Body temperature increased—Docetaxel—melanoma	0.000515	0.0019	CcSEcCtD
Avanafil—Asthenia—Docetaxel—melanoma	0.000467	0.00173	CcSEcCtD
Avanafil—Pruritus—Docetaxel—melanoma	0.000461	0.0017	CcSEcCtD
Avanafil—Diarrhoea—Docetaxel—melanoma	0.000446	0.00165	CcSEcCtD
Avanafil—Dizziness—Docetaxel—melanoma	0.000431	0.00159	CcSEcCtD
Avanafil—Vomiting—Docetaxel—melanoma	0.000414	0.00153	CcSEcCtD
Avanafil—Rash—Docetaxel—melanoma	0.000411	0.00152	CcSEcCtD
Avanafil—Dermatitis—Docetaxel—melanoma	0.00041	0.00152	CcSEcCtD
Avanafil—Headache—Docetaxel—melanoma	0.000408	0.00151	CcSEcCtD
Avanafil—Nausea—Docetaxel—melanoma	0.000387	0.00143	CcSEcCtD
